NCT06132425

Brief Summary

The purpose of this study is to 1) examine the importance of self-reported relief following exposure and 2) test whether positive-focused rehearsal following exposure can improve treatment outcomes for participants who endorse fear of public speaking. Exposure therapy is an extinction-based behavioral technique, often employed in the context of cognitive behavioral therapy. It involves strategically exposing an individual to a feared stimulus in an effort to generate new non-fear associations with that stimulus. Relief refers to the positive, rewarding emotions associated with the absence of an expected aversive outcome following exposure to a feared stimulus. In the current study, participants will engage in a series of short public speaking exposures that take place over two sessions. After every two exposures, participants will be asked to complete either a positive or neutral rehearsal exercise, consisting of recalling either positive or neutral aspects of the speech exposures. At multiple points throughout the study, participants will complete ratings of reward sensitivity, positive affect, relief, and expectancy of the aversive outcome. The investigators will test the following: 1) the relationship of reward sensitivity and positive affect with relief following exposures, 2) the relationship between relief after exposure and learning rate (i.e., learning that the feared stimulus does not predict an aversive outcome), 3) potential differences in exposure outcomes between the positive and neutral rehearsal groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 18, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 6, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 15, 2023

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2023

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

June 13, 2025

Completed
Last Updated

June 13, 2025

Status Verified

May 1, 2025

Enrollment Period

8 months

First QC Date

November 6, 2023

Results QC Date

December 6, 2024

Last Update Submit

May 28, 2025

Conditions

Keywords

anxietyextinctionpositive affectreward sensitivity

Outcome Measures

Primary Outcomes (1)

  • Change in Public Speaking Anxiety

    Responses to two self-reported questions assessing public speaking anxiety and avoidance (scored from 0-8, where higher scores reflect greater public speaking anxiety and avoidance) and responses to the Personal Report of Public Speaking Anxiety (PRPSA; scored from 34-170, where higher scores reflect greater public speaking anxiety symptom severity).

    Baseline through study completion, an average of 3 weeks.

Secondary Outcomes (5)

  • Learning Rate

    Sessions 1 through 2, an average of 2 weeks.

  • Relief Rate

    Sessions 1 through 2, an average of 2 weeks.

  • Change in Positive Affect

    Baseline through session 2, an average of 2 weeks.

  • Change in Reward Sensitivity

    Baseline through session 2, an average of 2 weeks.

  • Change in Reward Sensitivity

    Baseline through session 2, an average of 2 weeks.

Study Arms (2)

Positive Rehearsal

EXPERIMENTAL

After every two exposure trials, participants will complete a rehearsal exercise prompting reflection of expectancy violation and rehearsal of the inhibitory association between the conditional stimulus (i.e., speech) and the unconditional stimulus (i.e., rejection). During rehearsal, participants are prompted to identify positive emotional experiences associated with exposure trial outcomes.

Behavioral: ExposureBehavioral: Rehearsal

Neutral Rehearsal

ACTIVE COMPARATOR

After every two exposure trials, participants will complete a rehearsal exercise prompting reflection of expectancy violation and rehearsal of the inhibitory association between the conditional stimulus (i.e., speech) and the unconditional stimulus (i.e., rejection). During rehearsal, participants are prompted to maintain a neutral, non-emotional stance and focus on overall exposure trial outcomes.

Behavioral: ExposureBehavioral: Rehearsal

Interventions

ExposureBEHAVIORAL

All participants complete two study visits, each consisting of 8 exposure trials for durations of 1 minute each, resulting in a total of 16 exposures. For each exposure, participants are assigned a speech topic and given 1 minute to give an unprepared speech to two study confederates.

Neutral RehearsalPositive Rehearsal
RehearsalBEHAVIORAL

After every two exposures, participants will complete a rehearsal task where the participant is asked to use a positive or neutral approach to remember and recount the exposures they have just completed.

Neutral RehearsalPositive Rehearsal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English-speaking
  • Elevated score on public speaking anxiety/avoidance screening questions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Los Angeles

Los Angeles, California, 90095, United States

Location

MeSH Terms

Conditions

Anxiety DisordersGlossophobia

Condition Hierarchy (Ancestors)

Mental Disorders

Results Point of Contact

Title
Nora Barnes-Horowitz
Organization
University of California, Los Angeles

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 6, 2023

First Posted

November 15, 2023

Study Start

April 18, 2023

Primary Completion

December 12, 2023

Study Completion

December 12, 2023

Last Updated

June 13, 2025

Results First Posted

June 13, 2025

Record last verified: 2025-05

Locations